Literature DB >> 8513060

Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient.

R T Spielberger1, M J Falleroni, A J Coene, R A Larson.   

Abstract

The use of granulocyte transfusions during amphotericin B treatment of invasive fungal infections in granulocytopenic patients is controversial because of concern about pulmonary complications from leukostasis. Moreover, the administration of granulocyte-macrophage colony-stimulating factor (GM-CSF) to patients with active infections has been questioned because of reports that this cytokine inhibits neutrophil migration into areas of inflammation. We report a case in which the combined use of amphotericin B, granulocyte transfusions, and GM-CSF was safe and life-saving in a pancytopenic patient with disseminated fusarium infection. Histologic evidence of the migration of neutrophils into an area of active infection was found.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513060     DOI: 10.1093/clind/16.4.528

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

Review 1.  Key issues concerning fungistatic versus fungicidal drugs.

Authors:  J R Graybill; D S Burgess; T C Hardin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

Review 2.  Role of granulocyte transfusions in invasive fusariosis: systematic review and single-center experience.

Authors:  Sameer S Kadri; Kenneth E Remy; Jeffrey R Strich; Juan Gea-Banacloche; Susan F Leitman
Journal:  Transfusion       Date:  2015-04-09       Impact factor: 3.157

Review 3.  The potential role of granulocyte-macrophage colony stimulating factor in therapy of fungal infections: a commentary.

Authors:  G P Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-05       Impact factor: 3.267

Review 4.  Therapy for fungal infections in leukemia.

Authors:  R E Segal; G Y Minamoto
Journal:  Curr Oncol Rep       Date:  2001-05       Impact factor: 5.075

5.  Effects of the hematoregulatory peptide SK&F 107647 alone and in combination with amphotericin B against disseminated candidiasis in persistently neutropenic rabbits.

Authors:  C A Lyman; C Gonzalez; M Schneider; J Lee; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

6.  Role of granulocyte colony-stimulating factor in the treatment of mucormycosis.

Authors:  B Sahin; S Paydaş; E Coşar; K Biçakçi; B Hazar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

7.  Invasive infection with Fusarium chlamydosporum in a patient with aplastic anemia.

Authors:  B H Segal; T J Walsh; J M Liu; J D Wilson; K J Kwon-Chung
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

Review 8.  Opportunistic fusarial infections in humans.

Authors:  J Guarro; J Gené
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

9.  Successful treatment of catheter-related fusarial infection in immunocompromised children.

Authors:  E Velasco; C A Martins; M Nucci
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-08       Impact factor: 3.267

10.  Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis.

Authors:  J R Graybill; R Bocanegra; M Luther
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-08       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.